Extension of Time to File SOU

TANDEM

CELONOVA BIOSCIENCES, INC.

Trademark/Service Extension of Time

PTO Form 1581 (Rev 9/2005)
OMB No. 0651-0054 (Exp. 10/31/2017)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 85647086
LAW OFFICE ASSIGNED LAW OFFICE 117
MARK SECTION
MARK TANDEM (stylized and/or with design)
STANDARD CHARACTERS NO
USPTO-GENERATED IMAGE NO
OWNER SECTION
NAME CELONOVA BIOSCIENCES, INC.
STREET 18615 TUSCANY STONE, SUITE 100
CITY SAN ANTONIO
STATE Texas
ZIP/POSTAL CODE 78258
COUNTRY United States
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 010
CURRENT IDENTIFICATION Medical devices for embolization, namely, syringes and vials filled with embolic microspheres for embolization; Medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; Medical devices for embolization, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; Medical devices for embolization, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical devices for embolization, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical devices for embolization, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Medical devices for embolization, namely, embolic microspheres in the form of particles to treat vascular conditions; Medical microspheres for transarterial embolization of tumors, chemoembolization, transarterial chemoembolization, lesion devascularization, lobe devascularization, and proximal embolization; Medical microspheres for the treatment of hypervascular tumors and arteriovenous malformations; Medical microspheres for super selective, targeted chemoembolization of a hypervascular tissue or tumor; Drug delivery device, namely, a drug delivery microsphere for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment; Drug delivery device, namely, a drug delivery bead for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 2
ONGOING EFFORT product or service research or development; steps to obtain required governmental approval
ALLOWANCE MAIL DATE 07/23/2013
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT 150
TOTAL AMOUNT 150
SIGNATURE SECTION
SIGNATURE /SW/
SIGNATORY'S NAME Scott D. Woldow
SIGNATORY'S POSITION Attorney of Record, DC bar member
DATE SIGNED 07/21/2014
SIGNATORY'S PHONE NUMBER 202-263-4300
FILING INFORMATION
SUBMIT DATE Mon Jul 21 16:03:34 EDT 2014
TEAS STAMP USPTO/ESU-XX.XXX.XXX.XXX-
20140721160334032907-8564
7086-5008576ca77b3a17bc8f
88398947905bba18ac8f95c94
cf51b5aba9c59207aaade-CC-
2712-20140721155956252373



PTO Form 1581 (Rev 9/2005)
OMB No. 0651-0054 (Exp. 10/31/2017)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: TANDEM (stylized and/or with design)
SERIAL NUMBER: 85647086

The applicant, CELONOVA BIOSCIENCES, INC., having an address of
      18615 TUSCANY STONE, SUITE 100
      SAN ANTONIO, Texas 78258
      United States
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 07/23/2013.

For International Class 010:
Current identification: Medical devices for embolization, namely, syringes and vials filled with embolic microspheres for embolization; Medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; Medical devices for embolization, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; Medical devices for embolization, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical devices for embolization, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical devices for embolization, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Medical devices for embolization, namely, embolic microspheres in the form of particles to treat vascular conditions; Medical microspheres for transarterial embolization of tumors, chemoembolization, transarterial chemoembolization, lesion devascularization, lobe devascularization, and proximal embolization; Medical microspheres for the treatment of hypervascular tumors and arteriovenous malformations; Medical microspheres for super selective, targeted chemoembolization of a hypervascular tissue or tumor; Drug delivery device, namely, a drug delivery microsphere for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment; Drug delivery device, namely, a drug delivery bead for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development; steps to obtain required governmental approval



A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other person has the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /SW/      Date Signed: 07/21/2014
Signatory's Name: Scott D. Woldow
Signatory's Position: Attorney of Record, DC bar member
Signatory's Phone: 202-263-4300

RAM Sale Number: 85647086
RAM Accounting Date: 07/22/2014

Serial Number: 85647086
Internet Transmission Date: Mon Jul 21 16:03:34 EDT 2014
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XXX-201407211603340
32907-85647086-5008576ca77b3a17bc8f88398
947905bba18ac8f95c94cf51b5aba9c59207aaad
e-CC-2712-20140721155956252373



Extension of Time to File SOU [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed